Talk to your doctor about any possible risks involved before using this product
Quick Answer: Semaglutide does not directly cause frequent urination and is not listed as a common side effect in FDA prescribing information
Bottom line: Its best not to combine products that have GLP-1like effects, and always talk to your provider before adding anything new for weight loss or blood sugar control
The FDA has issued safety communications regarding compounded semaglutide products, warning about adverse events related to improper compounding and dosing errors
To reduce regain risk, we often consider: Periodic weight monitoring Body composition tracking when appropriate Scheduled follow up visits Ongoing adjustment of nutrition and activity plans For some individuals, extended low dose therapy or gradual transition approaches may be appropriate
In practice, we continue as long as the medicine is helping your glucose levels, weight and overall health, and as long as side effects are manageable and it remains affordable and available